SCHEMBL20056482

SCHEMBL20056482

CNC(=O)c1cc(F)cc(-c2ccc(O)c(Cl)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 6/20 0.47
HSD17B2 P37059 6/20 0.47
MAP4K4 O95819 1/20 0.43
ESR2 Q92731 3/20 0.41
HDAC2 Q92769 1/20 0.41
ESRRG P62508 1/20 0.40
BACE1 P56817 1/20 0.40
ESR1 P03372 2/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
KAT6A Q92794 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HTR1A P08908 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16076888 0.81 HSD17B1 (0.54) HSD17B1HSD17B2ESR2
SCHEMBL20056601 0.80 HSD17B1 (0.52) HSD17B1HSD17B2ESR2HDAC2ESRRG
SCHEMBL30147643 0.78 HDAC6 (0.49) HSD17B1HSD17B2MAP4K4ESR2RAB9A
SCHEMBL14161443 0.75 MAP4K4 (0.43) HSD17B1HSD17B2MAP4K4BACE1KDM4E
SCHEMBL2662442 0.75 HSP90AA1 (0.53) HDAC2RAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL30147551 0.74 HDAC6 (0.52) HDAC2SMN1; SMN2HPGD
SCHEMBL114726 0.73 CES2 (0.54) MAP4K4HDAC2RAB9ANPC1SMN1; SMN2
SCHEMBL13568513 0.72 TAS1R3 (0.54) MAP4K4HDAC2RAB9ANPC1SMN1; SMN2
SCHEMBL6119709 0.70 HCAR1 (0.59) HSD17B1HSD17B2MAP4K4HDAC2SMN1; SMN2
SCHEMBL19391124 0.70 KDM4E (0.65) HSD17B1HSD17B2ESR2HDAC2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970353-B1 MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS VERTEX PHARMA (US) 2018-04-18 EP disclosed